European Archives - Page 41 of 1095 - European Medical Journal

Butter vs. Plant-Based Oils: Groundbreaking Study Reveals Butter Linked to Higher Death Rates

Butter linked to higher mortality; plant-based oils reduce death risks. Study urges dietary swaps for long-term health.

Cartoon brain on green background

Phase 2 trial begins for psychedelic-based depression treatment

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.

Niraparib Shows Promise in Ovarian Cancer: ESGO 2025

The MITO 40 study, presented at ESGO 2025, highlights promising results for Niraparib as a maintenance treatment in ovarian cancer patients with no residual disease post-surgery.

Updated ATHENA-MONO Data Confirms Rucaparib Benefits: ESGO 2025

Rucaparib showed longer progression-free survival, chemotherapy-free interval, and time to first subsequent treatment in advanced ovarian cancer patients, according to updated results from the ATHENA-MONO study.

Treatment Advances in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

The primary treatment for intermediate and high-risk NMIBC includes transurethral resection of the bladder tumour.

Chronic Rhinosinusitis Linked to Lung Disease

A new study has found strong associations between chronic rhinosinusitis and chronic airflow limitation, lower airway symptoms, and smoking-related lung diseases.

Accuracy of Preoperative Tumour Size Assessment in Cervical Cancer: ESGO 2025

ESGO 2025 study reveals overestimation of preoperative tumour size in stage IB2 cervical cancer, influencing adjuvant therapy decisions.

New AI-Powered Model Enhances Early Ovarian Cancer Diagnosis

Advanced ensemble model integrating clinical variables, O-RADS, and deep learning (DL) radiomics can significantly enhance the accuracy of ovarian cancer diagnosis according to recent research.

New Diagnostic Index Improves Ovarian Cancer Detection: ESGO 2025

At the 2025 ESGO Annual Meeting, researchers unveiled two new diagnostic indices “Vienna Index” and “Top Vienna Index” which combine age with existing ovarian cancer biomarkers, significantly improving detection accuracy.

Semaglutide Reduces Alcohol Cravings in Adults with Alcohol Use Disorder

Low-dose semaglutide reduces alcohol cravings and some drinking behaviours in adults with alcohol use disorder.